Together with the finding that the growth of KRAS‐mutated cancers, including pancreatic and lung cancers, is strongly dependent on glutamine metabolism,16, 65 this study suggests inhibition of glutamine uptake as a potential therapeutic target in KRAS‐mutated various human malignancies. This evidence concerns the gene KRAS and lung carcinoma.